125 related articles for article (PubMed ID: 24508663)
1. Acetylcholine affects osteocytic MLO-Y4 cells via acetylcholine receptors.
Ma Y; Li X; Fu J; Li Y; Gao L; Yang L; Zhang P; Shen J; Wang H
Mol Cell Endocrinol; 2014 Mar; 384(1-2):155-64. PubMed ID: 24508663
[TBL] [Abstract][Full Text] [Related]
2. Corticosterone regulates the expression of neuropeptide Y and reelin in MLO-Y4 cells.
Ma Y; Wu X; Li X; Fu J; Shen J; Li X; Wang H
Mol Cells; 2012 Jun; 33(6):611-6. PubMed ID: 22610366
[TBL] [Abstract][Full Text] [Related]
3. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
4. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
[TBL] [Abstract][Full Text] [Related]
5. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
Heino TJ; Hentunen TA; Väänänen HK
Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.
Bliziotes M; Eshleman A; Burt-Pichat B; Zhang XW; Hashimoto J; Wiren K; Chenu C
Bone; 2006 Dec; 39(6):1313-21. PubMed ID: 16884969
[TBL] [Abstract][Full Text] [Related]
7. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic signaling affect osteoclastogenesis via osteocytic MLO-Y4 cells' RANKL production.
Yao Q; Liang H; Huang B; Xiang L; Wang T; Xiong Y; Yang B; Guo Y; Gong P
Biochem Biophys Res Commun; 2017 Jul; 488(4):634-640. PubMed ID: 27823934
[TBL] [Abstract][Full Text] [Related]
9. Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers.
Welldon KJ; Findlay DM; Evdokiou A; Ormsby RT; Atkins GJ
Mol Cell Endocrinol; 2013 Aug; 376(1-2):85-92. PubMed ID: 23791847
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an osteocyte-like cell line, MLO-Y4.
Kato Y; Windle JJ; Koop BA; Mundy GR; Bonewald LF
J Bone Miner Res; 1997 Dec; 12(12):2014-23. PubMed ID: 9421234
[TBL] [Abstract][Full Text] [Related]
11. The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts.
Persson E; Lerner UH
J Cell Biochem; 2011 Dec; 112(12):3732-41. PubMed ID: 21815197
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
[TBL] [Abstract][Full Text] [Related]
13. Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts.
Sato T; Abe T; Chida D; Nakamoto N; Hori N; Kokabu S; Sakata Y; Tomaru Y; Iwata T; Usui M; Aiko K; Yoda T
FEBS Lett; 2010 Feb; 584(4):817-24. PubMed ID: 20067796
[TBL] [Abstract][Full Text] [Related]
14. Glucose uptake inhibition decreases expressions of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteocalcin in osteocytic MLO-Y4-A2 cells.
Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
Am J Physiol Endocrinol Metab; 2018 Feb; 314(2):E115-E123. PubMed ID: 29018002
[TBL] [Abstract][Full Text] [Related]
15. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
16. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
[TBL] [Abstract][Full Text] [Related]
17. Murine embryonic stem cell line CGR8 expresses all subtypes of muscarinic receptors and multiple nicotinic receptor subunits: Down-regulation of α4- and β4-subunits during early differentiation.
Kaltwasser S; Schmitz L; Michel-Schmidt R; Anspach L; Kirkpatrick CJ; Wessler I
Int Immunopharmacol; 2015 Nov; 29(1):110-4. PubMed ID: 26299974
[TBL] [Abstract][Full Text] [Related]
18. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation.
Zhang K; Barragan-Adjemian C; Ye L; Kotha S; Dallas M; Lu Y; Zhao S; Harris M; Harris SE; Feng JQ; Bonewald LF
Mol Cell Biol; 2006 Jun; 26(12):4539-52. PubMed ID: 16738320
[TBL] [Abstract][Full Text] [Related]
19. Regulation of osteoblast differentiation by osteocytes cultured on sclerostin antibody conjugated TiO
Chen M; Hu Y; Li M; Chen M; Shen X; Luo Z; Mu C; Yang W; Liu P; Cai K
Colloids Surf B Biointerfaces; 2019 Mar; 175():663-670. PubMed ID: 30590327
[TBL] [Abstract][Full Text] [Related]
20. RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells.
Mulcahy LE; Taylor D; Lee TC; Duffy GP
Bone; 2011 Feb; 48(2):182-8. PubMed ID: 20854946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
